酸枣仁水提物通过抑制GPR50调控突触可塑性改善小鼠PTSD样行为
高子璇 , 何存宝 , 杨绍杰 , 王斌 , 朱国旗 , 程卉 , 陈丽霞
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (8) : 1053 -1063.
酸枣仁水提物通过抑制GPR50调控突触可塑性改善小鼠PTSD样行为
Amelioration of PTSD-like behaviors in mice by the aqueous extract of Ziziphi Spinosae Semen via inhibition of GPR50 and regulation of synaptic plasticity
目的: 评价酸枣仁(Ziziphi Spinosae Semen,ZSS)水提物对单次长时程应激(single prolonged stress,SPS)诱导的小鼠创伤后应激障碍(post-traumatic stress disorder,PTSD)样行为的作用,并从 G 蛋白偶联受体 50(G protein-coupled receptor 50,GPR50)和海马突触可塑性角度探究其可能的作用机制。方法: UPLC-UV 检测酸枣仁水提物中主要成分酸枣仁皂苷 A、B 含量;将 C57BL/6 小鼠随机分为正常对照组、SPS 模型组、SPS+酸枣仁水提物低、中、高剂量组及 SPS+帕罗西汀组,采用行为学实验评价 SPS 小鼠的 PTSD 样行为;分子对接验证酸枣仁皂苷 A、B 分别与 GPR50 结合的稳定性;Western blot 联合免疫荧光检测小鼠海马组织 GPR50、 PSD95、 GluN2A 和 GluN2B 蛋白表达水平;生物信息分析学预测酸枣仁治疗 PTSD 的关键靶点。结果: 本研究对酸枣仁水提物中主要药效成分酸枣仁皂苷 A、B 进行了定性和定量分析;与正常组比较,SPS 模型组小鼠表现出焦虑、抑郁和恐惧记忆消退困难等 PTSD 样行为(P<0.05),海马 GPR50 蛋白表达升高,突触可塑性相关蛋白 PSD95、 GluN2A 和 GluN2B 表达异常,而酸枣仁水提物可明显改善 SPS 小鼠的 PTSD 样行为 (P<0.05), 并抑制 GPR50 表达 (P<0.05), 改善 PSD95、 GluN2A 和 GluN2B 蛋白的异常表达;筛选酸枣仁水提物作用 PTSD 潜在靶点 209 个,分别富集在抑制突触可塑性损伤及发挥抗氧化特性等功能;分子对接显示酸枣仁水提物中主要成分酸枣仁皂苷 A、B 与 GPR50 结合稳定。结论: 酸枣仁水提物能改善 SPS 诱导的小鼠 PTSD 样行为,其机制可能与抑制 GPR50 改善突触可塑性损伤相关。
AIM: To evaluate the effects of the aqueous extract of Ziziphi Spinosae Semen (ZSS) on single prolonged stress (SPS)-induced post-traumatic stress disorder (PTSD)-like behaviors in mice, and to explore its potential mechanism from the perspective of hippocampal G protein-coupled receptor 50 (GPR50) and synaptic plasticity. METHODS: The UPLC-UV method was employed to determine the content of the main components, saponin A and saponin B, in the aqueous extract of ZSS. C57BL/6 mice were randomly divided into Control group, SPS group, SPS+ZSS-L, M, H groups and SPS+PRX group. Behavioral experiments were used to evaluate PTSD-like behaviors in SPS mice. Molecular docking was employed to evaluate the stability of the binding between the active ingredients in aqueous extract of ZSS and GPR50. Western blot combined with immunofluorescence were applied to detect GPR50, PSD95, GluN2A, and GluN2B protein expression in mouse hippocampal tissue. Bioinformatics analysis was used to predict key targets for ZSS treatment of PTSD. RESULTS: This study conducted qualitative and quantitative analyses of the main active ingredients saponin A and B in the aqueous extract of ZSS. Compared with the Control group, mice in the SPS group exhibited PTSD-like behaviors such as anxiety, depression, and difficulty in fear memory extinction (P<0.05), with elevated expression of GPR50 protein in the hippocampus and abnormal expression of synaptic plasticity-related proteins PSD95, GluN2A, and GluN2B. The aqueous extract of ZSS significantly improved PTSD behaviors in SPS mice (P<0.05) and inhibited GPR50 expression (P<0.05). A total of 209 potential targets of the aqueous extract of ZSS for treating PTSD were screened. These targets were enriched in pathways associated with functions such as inhibiting impaired synaptic plasticity and exerting antioxidant properties. Molecular docking demonstrated that ZSS saponin A and saponin B, bind stably to GPR50. CONCLUSION: The aqueous extract of ZSS can ameliorate SPS-induced PTSD-like behaviors in mice, and its mechanism may be associated with the inhibition of GPR50 to alleviate synaptic plasticity impairment.
| [1] |
|
| [2] |
|
| [3] |
何存宝, 杨绍杰, 朱国旗. 4-(芳基乙炔基)-吡咯并[2, 3-d]嘧啶通过抑制 mGluR5 调控 ERK1/2-SGK1 信号通路改善小鼠创伤后应激障碍[J].南方医科大学学报, 2025, 45(4): 765-773. |
| [4] |
|
| [5] |
|
| [6] |
李园, 邓昕, 黄成, |
| [7] |
程宏愽, 刘献, 尚慧莹, |
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
兰道亮, 姚颖, 陈艳, |
| [17] |
|
| [18] |
|
| [19] |
杨静怡, 朱国旗, 陈玉状, |
| [20] |
丁灵, 王欣, 上官惠子, |
| [21] |
区绮琪, 王鹏, 王茎. 浅析宫廷医学辨治不寐特色[J].中华中医药杂志, 2021, 36(6): 3691-3694. |
| [22] |
杨绍杰, 陈玉状, 朱国旗. 从心肾探析创伤后应激障碍病机及中药防治研究[J].中医药临床杂志, 2021, 33(6): 1011-1015. |
| [23] |
唐言波. 基于中医古籍和数据挖掘探讨中医辨治失眠的用药规律[J].贵州医药, 2024, 48(9): 1460-1462. |
| [24] |
赵博深, 史磊磊, 安宇宇, |
| [25] |
|
| [26] |
Khan MZ, He L, |
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
Pereyra G, Mateo MI, Miaja P, |
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
国家自然科学基金(82404890)
安徽省高等学校科学研究项目(2024AH040137)
安徽省高等学校科学研究项目(2024AH051044)
新安医学与中医药现代化研究所“揭榜挂帅”项目(2023CXMMTCM013)
/
| 〈 |
|
〉 |